Cannara Biotech (OTCMKTS:CNBTF) Stock Price Up 0.7% – Time to Buy?
by Amy Steele · The Cerbat GemCannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s stock price traded up 0.7% during mid-day trading on Thursday . The stock traded as high as $1.44 and last traded at $1.44. 5,001 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 33,127 shares. The stock had previously closed at $1.4305.
Cannara Biotech Price Performance
The stock has a 50 day moving average price of $1.35 and a 200 day moving average price of $1.31.
Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.
The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.